Posts

Showing posts from November 8, 2026

Antibiotics and Resistance: Are New Molecules in the Pipeline? Researchers in Tours Explore New Antibacterial Strategies

Image
ntibiotic resistance is one of the major challenges facing modern medicine. As bacterial pathogens increasingly develop resistance to existing treatments, the search for new antibacterial molecules has become an essential part of antimicrobial research. However, discovering a promising compound is only the first step: understanding its mechanism of action, assessing its toxicity and determining whether it can be developed into an effective treatment require years of multidisciplinary investigation. At the University of Tours, France, researchers from two complementary laboratories are working on precisely these questions. Their research combines organic chemistry and bacteriology to investigate new antibacterial compounds inspired by natural molecules. On Thursday, November 19, 2026, Dr. Émilie Camiade and Dr. Julien Pétrignet will present their work during a new MédiSciences conference entitled “Antibiotics and Resistance: Are New Molecules in the Pipeline?” You can attend the confere...

A Phage-Derived Protein Reveals a New Strategy to Block Bacterial Cell Wall Synthesis

Image
A research team at the Nara Institute of Science and Technology (NAIST) in Japan has uncovered how a small protein produced by a bacteriophage can interfere with an essential mechanism of bacterial survival. The discovery, reported by The Microbiologist on November 10, 2026, focuses on SglPP7, a phage-derived lysis protein that blocks MurJ, a membrane transporter involved in bacterial cell wall synthesis. Structural illustration showing how the bacteriophage-derived protein SglPP7 binds to MurJ and locks the transporter in an outward-facing conformation, disrupting lipid II transport and bacterial cell wall synthesis. Adapted from Hosoda et al., PLOS Biology (2026). The work was led by researchers from NAIST’s Laboratory of Structural Life Science, including Professor Tomoya Tsukazaki and Assistant Professor Hidetaka Kohga, together with colleagues from the institute and the Japan Synchrotron Radiation Research Institute. Their findings were published in PLOS Biology on October 27, 20...

From Bacterial Morphotypes to Phage Therapy: How Thomas Byrd’s Research Helped Shape the Fight Against Mycobacterium abscessus

Image
For nearly two decades, Thomas Byrd, a physician-scientist at the University of New Mexico (UNM) School of Medicine, investigated the biology of a bacterium that was not yet widely recognised as a major clinical challenge. His research focused on Mycobacterium abscessus , a nontuberculous mycobacterium capable of causing difficult-to-treat pulmonary and extrapulmonary infections. At the time, the work was driven primarily by fundamental scientific questions about bacterial behaviour and pathogenicity. Today, as antimicrobial resistance increasingly limits treatment options, those early findings have acquired renewed significance, including in the development of bacteriophage-based approaches. Thomas Byrd, MD, Emeritus Professor of Infectious Diseases at the University of New Mexico School of Medicine. His foundational research on Mycobacterium abscessus helped inform the development of phage-based therapeutic approaches. Photo: Jeff Sargent / UNM Health Sciences. In a profile published...

How Bacteriophages Insert and Remove DNA with Remarkable Precision: New Insights into Large Serine Integrases

Image
Bacteriophages are best known for their ability to infect bacteria, replicate within their hosts and, in many cases, destroy bacterial cells. However, their biological machinery also contains sophisticated molecular tools that could have applications far beyond antimicrobial research. Among the most interesting are large serine integrases, enzymes that allow certain phages to insert their genetic material into bacterial chromosomes and subsequently remove it through a highly controlled recombination process. Graphical abstract illustrating how large serine integrases and recombination directionality factors (RDFs) control DNA integration and excision. From Shin et al., Molecular Cell (2026). A new study from researchers at the University of Chicago, published in Molecular Cell and highlighted by the university on November 12, 2026, provides new structural insights into how these enzymes control the direction of DNA recombination. By using cryo-electron microscopy to capture different ...

Inhaled Phage Therapy in Critically Ill Patients: New Clinical Evidence from a 96-Patient Study

Image
A new investigation into inhaled bacteriophage therapy The clinical development of bacteriophage therapy is increasingly exploring administration routes beyond conventional intravenous and topical applications. Among these approaches, inhalation offers an interesting possibility for treating respiratory infections by delivering bacteriophages directly to the respiratory tract. A new study published on November 12, 2026, in Frontiers in Medicine provides additional clinical data on this strategy. Entitled Hospital-adapted inhaled phage cocktail as a component of antimicrobial therapy in chronically critically ill patients with lower respiratory tract infections , the research examines whether inhaled bacteriophages can be safely incorporated into antibiotic treatment and potentially contribute to antimicrobial stewardship. Inhaled bacteriophage therapy: phages are delivered directly to the respiratory tract using a nebulizer. Illustrative photograph; the patient is not part of the 2026...

Most Consulted Articles

Bacteriophages Disarm Inflammation-Associated E. coli Without Erasing the Gut Microbiome in IBD

🌐 PhageAtLabs® — a global interactive mapping of academic laboratories in phage research.

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

The Phage Therapy in the spotlight !

Phagos Launches CAPHARD, a 900-Million-Parameter AI Model to Predict Phage–Bacteria Interactions